Eli Lilly Netherlands

Eli Lilly Netherlands is owned by Eli Lilly.

Eli Lilly is one of the...

Eli Lilly is a company listed under the stock ticker LLY (US).

Eli Lilly has a direct presence in 19 countries.

They are in:

Acquisition, funding and merger involving Eli Lilly.

Eli Lilly has announced the acquisition of Point Biopharma (posted on December 5 2023).
Eli Lilly has announced the acquisition of Point Biopharma (posted on October 6 2023).
Eli Lilly has acquired Versanis Bio (posted on August 15 2023).
Eli Lilly has announced the acquisition of Versanis Bio (posted on July 18 2023).
Eli Lilly has announced the acquisition of Sigilon Therapeutics (posted on June 30 2023).
Eli Lilly has announced the acquisition of Dice Therapeutics (posted on June 22 2023).
Eli Lilly has acquired Akouos (posted on December 2 2022).
Eli Lilly has announced the acquisition of Akouos (posted on October 21 2022).
See more news about Eli Lilly Hide news involving Eli Lilly

View the org chart displaying its 3 main executives

Anat Ashkenazi, Senior Vice President and Chief Financial Officer, will leave the company on Jul. 31, 2024 (posted on June 5 2024).
Melissa Seymour will join the company as Executive Vice President of Global Quality on Jul. 22, 2024 (posted on June 5 2024).
Alonzo Weems, Executive Vice President, Enterprise Risk Management and Chief Ethics and Compliance Officer, will retire on Dec. 31, 2024 (posted on May 16 2024).

Create your alert
to follow the executive moves at Eli Lilly Netherlands.